BetterScholar BetterScholar

L. Else

Antiviral Therapy, Clinical pharmacology and therapy, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Clinical Infectious Diseases, PLoS Medicine, The Lancet HIV, Journal of Pharmaceutical and Biomedical Analysis Show more
9
Role
Title
Level Year L/R
🦁 Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
7 auth. L. Else, V. Watson, J. Tjia, Andrew Hughes, M. Siccardi, S. Khoo, ... D. Back 		7 2010
7
🦁
🦁 Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Male and Female Genital Tract
L. Else, Stephen Taylor, D. Back, S. Khoo 		6 2011
6
🦁
🐜 A Compartmental Pharmacokinetic Evaluation of Long‐Acting Rilpivirine in HIV‐Negative Volunteers for Pre‐Exposure Prophylaxis
11 auth. A. Jackson, L. Else, P. Mesquita, D. Egan, D. Back, Zeenat Karolia, ... L. Ringner-Nackter, C. Higgs, B. Herold, B. Gazzard, M. Boffito 		6 2014
6
🐜
🐜 Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
11 auth. K. Scarsi, Kristin M. Darin, S. Nakalema, D. Back, P. Byakika-Kibwika, L. Else, ... S. Dilly Penchala, Allan Buzibye, S. Cohn, C. Merry, M. Lamorde 		6 2015
6
🐜
🐜 Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)
23 auth. C. Waitt, C. Orrell, S. Walimbwa, Yashna Singh, K. Kintu, Bryony Simmons, J. Kaboggoza, Mary Sihlangu, Julie-Anne Coombs, T. Malaba, ... J. Byamugisha, Alieu Amara, J. Gini, L. Else, Christie Heiburg, E. Hodel, H. Reynolds, U. Mehta, P. Byakika-Kibwika, A. Hill, L. Myer, M. Lamorde, S. Khoo 		6 2019
6
🐜
🐜 Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study
16 auth. L. Dickinson, J. Amin, L. Else, M. Boffito, D. Egan, A. Owen, S. Khoo, D. Back, C. Orrell, A. Clarke, ... M. Losso, P. Phanuphak, D. Carey, D. Cooper, S. Emery, R. Puls 		6 2015
6
🐜
🐜 Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment.
22 auth. I. McGowan, C. Dezzutti, A. Siegel, J. Engstrom, A. Nikiforov, K. Duffill, Cory Shetler, N. Richardson-Harman, Kaleab Z. Abebe, D. Back, ... L. Else, D. Egan, S. Khoo, J. Egan, R. Stall, P. Williams, K. Rehman, Amy P. Adler, R. Brand, Beatrice A Chen, S. Achilles, Ross D. Cranston 		6 2016
6
🐜
🦁 Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid)
L. Else, Stephen Taylor, D. Back, S. Khoo 		5 2011
5
🦁
🐜 The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
9 auth. Alieu Amara, S. D. Penchala, L. Else, C. Hale, R. Fitzgerald, L. Walker, ... Rebecca L. Lyons, T. Fletcher, S. Khoo 		5 2021
5
🐜